RGT 3.09% 47.0¢ argent biopharma limited

Ann: Canaccord to Lead LSE Listing and $4.75m Placement Closed, page-109

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 14,051 Posts.
    lightbulb Created with Sketch. 2400
    There are lots of reasons why a year on MXC should grow - the revenue streams have only grown since the sale of Dema to CG - and the influence CG had in getting some of those connections. That is why the September quarterly report should be of great interest to shareholders. In 12 months time the Malta operation (construction wise) should be well advanced.

    This is the second time you mentioned the ASX ordering MXC to produce details on CG in writing - and this will be the second time that will ask you whether you can produce evidence of that - honest request as I have not seen anything like that demand and I would be very interested to see it.

    The MM industry as a whole is really in its infancy and entering into a consolidation phase. It is much more prudent to let MXC line up its ducks before making an attempt at a take over - after all the hard work has been done. The SP has been manipulated to hell and back as most of us have worked out already so holding the SP down at low levels makes MXC an attractive target - and in 12 months time the momentum of the MM industry would have grown considerably.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
47.0¢
Change
-0.015(3.09%)
Mkt cap ! $23.22M
Open High Low Value Volume
49.5¢ 50.0¢ 46.0¢ $48.58K 102.3K

Buyers (Bids)

No. Vol. Price($)
2 2500 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 5000 1
View Market Depth
Last trade - 15.23pm 11/10/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.